Results 31 to 40 of about 59,761 (296)
Selective Serotonin Reuptake Inhibitors
, 2016 Selective serotonergic reuptake inhibitors (SSRIs) are a class of medications used frequently to address issues related to stroke and post-stroke recovery. Health care providers who care for stroke patients will need to familiarize themselves with their applications in stroke treatment.
Ali Saad +2 more
+5 more sources
Duloxetine-induced rapid eye movement sleep behavior disorder: a case report
BMC Psychiatry, 2017 Background Tricyclic antidepressants and selective serotonin reuptake inhibitors have been reported to induce the symptoms of rapid eye movement (REM) sleep behavior disorder (RBD) or to exacerbate REM sleep without atonia.
Lu Tan +6 more
doaj +1 more source
Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo. [PDF]
, 2013 In this study, we characterized early biochemical changes associated with sertraline and placebo administration and changes associated with a reduction in depressive symptoms in patients with major depressive disorder (MDD).
Bogdanov, MB +11 more
core +2 more sources
Depressed youth, suicidality and antidepressants [PDF]
, 2005 The document attached has been archived with permission from the editor of the Medical Journal of Australia. An external link to the publisher’s copy is included.Robert D Goldney, Peter R Mansfield, Melissa K Raven, Jon N Jureidini, Joseph M Rey, Michael
Dudley, M. +6 more
core +1 more source
Influence of mirtazapine on salivary cortisol in depressed patients [PDF]
, 2003 Unlike other antidepressants, mirtazapine does not inhibit the reuptake of norepinephrine or serotonin but acts as an antagonist at presynaptic alpha(2)-receptors, at postsynaptic 5-HT2 and 5-HT3 receptors, and at histaminergic H1 receptors. Furthermore,
Baghai, Thomas C. +3 more
core +1 more source
South African Family Practice, 2015 Switching antidepressants because of lack of efficacy or unacceptable side effects, while often required in general practice, may result in toxic drug-drug interactions, worsening depression or unpleasant discontinuation reactions.
K. Outhoff
doaj +1 more source
Divergent effect of fluoxetine on the response to physical or chemical stressors in zebrafish [PDF]
PeerJ, 2017 Fluoxetine is a selective serotonin reuptake inhibitor that increases serotonin concentration in the central nervous system and modulates various systems, including the control of sympathetic outflow and the hypothalamus–pituitary–adrenal. However, it is
Murilo S. Abreu +4 more
doaj +2 more sources
Plasma Serotonin and Cardiovascular Outcomes in Chronic Kidney Disease
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Background Platelet‐poor plasma serotonin levels are associated with adverse cardiovascular outcomes. Although plasma serotonin levels increase in chronic kidney disease, the cardiovascular implications remain unknown.
Daniel Edmonston +2 more
doaj +1 more source
Recording and treatment of premenstrual syndrome in UK general practice: a retrospective cohort study [PDF]
, 2016 OBJECTIVES: To investigate the rate of recording of premenstrual syndrome diagnoses in UK primary care and describe pharmacological treatments initiated following a premenstrual syndrome (PMS) diagnosis. DESIGN: Retrospective cohort study.
Nazareth, I, Petersen, I, Sammon, CJ
core +1 more source
Is there a potential of misuse for venlafaxine and bupropion? [PDF]
, 2018 © 2018 Schifano and Chiappini. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the ...
Anderson +64 more
core +3 more sources